Relevance of Poly(ADP-ribose) Polymerase 1 (PARP1) in Experimental Colitis

被引：0
|
作者：
Larmonier, Claire B.
Shehab, Kareem W.
McFadden, Rita-Marie T.
Hill, Faihza M.
Alizadeh, Darya
Thurston, Robert D.
Kiela, Pawel R.
Ghishan, Fayez K.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1720
引用
收藏
页码：S644 / S644
页数：1
相关论文
共 50 条
  • [41] FISETIN INHIBITS POLY(ADP-RIBOSE)POLYMERASE (PARP)-1 AND THE RELEASE OF INFLAMMATORY CYTOKINES
    Weseler, A. R.
    Geraets, L.
    Wouters, E. F. M.
    Bast, A.
    Hageman, G. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 380 (03) : 258 - 258
  • [42] The 3′-5′ Exonuclease, TREX1, Interacts with Poly(ADP-ribose) Polymerase-1 (PARP1) in Response to DNA Damage
    Miyazaki, Takuya
    Kim, Yong-Soo
    Yoon, Jeong-Heon
    Wang, Hongsheng
    Morse, Herbert C., III
    BLOOD, 2012, 120 (21)
  • [43] Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53
    Shin, Hyeon-Jun
    Kwon, Hyuk-Kwon
    Lee, Jae-Hyeok
    Gui, Xiangai
    Achek, Asma
    Kim, Jae-Ho
    Choi, Sangdun
    SCIENTIFIC REPORTS, 2015, 5
  • [44] Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53
    Hyeon-Jun Shin
    Hyuk-Kwon Kwon
    Jae-Hyeok Lee
    Xiangai Gui
    Asma Achek
    Jae-Ho Kim
    Sangdun Choi
    Scientific Reports, 5
  • [45] Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas
    Csonka, Tamas
    Murnyak, Balaks
    Szepesi, Rita
    Kurucz, Andrea
    Klekner, Almos
    Hortobagyi, Tibor
    FOLIA NEUROPATHOLOGICA, 2014, 52 (02) : 111 - 120
  • [46] The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity
    Zhai, Lili
    Li, Shuai
    Li, Xiaoyan
    Li, Huilan
    Gu, Feng
    Guo, Xiaojing
    Liu, Fangfang
    Zhahg, Xinmin
    Fu, Li
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (02) : 130 - 137
  • [47] Poly (ADP-ribose) polymerase-1 (PARP1) inhibitor BSI-201 in combination with temozolomide (TMZ) in malignant glioma
    Blakeley, J. O.
    Ye, X.
    Grossman, S. A.
    Mikkelsen, T.
    Rosenfeld, M. R.
    Bradley, C. R.
    Eichler, A. F.
    Nabors, L. B.
    Desideri, S.
    Supko, J. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Poly(ADP-ribose)polymerase-1 (PARP) activation and diabetic neuropathic pain
    Ilnytska, O
    Mashtalir, N
    Drel, VR
    Pacher, P
    Yorek, MA
    Obrosova, IG
    FASEB JOURNAL, 2006, 20 (04): : A777 - A778
  • [49] Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities
    Rajawat, Jyotika
    Shukla, Nidhi
    Mishra, Durga Prasad
    MEDICINAL RESEARCH REVIEWS, 2017, 37 (06) : 1461 - 1491
  • [50] Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines
    Ogino, Hideki
    Nakayama, Robert
    Sakamoto, Hiromi
    Yoshida, Teruhiko
    Sugimura, Takashi
    Masutani, Mitsuko
    CANCER GENETICS AND CYTOGENETICS, 2010, 197 (01) : 8 - 15
12345